Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 71% · prior close shown (market closed)
C. H. ROBINSON WORLDWIDE, INC. shows stable business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +19% YoY in Q2 FY2026.
2 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 6d ago
CHRW's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on CHRW.
Free accounts see more of this; Premium sees all of it.
Reported figures for C. H. ROBINSON WORLDWIDE, INC. — research only, not investment advice.
Updated
What happened recently for C. H. ROBINSON WORLDWIDE, INC. (CHRW) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
AlphaOS industries
Investment snapshot
CHRW's AI investment thesis
Upgrade to Premium for CHRW's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$148.24
Market cap
$17.32B
Profitable
Yes
Revenue $16.23B
Net income
$587.08M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for C. H. ROBINSON WORLDWIDE, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow C. H. ROBINSON WORLDWIDE, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.
Structured stock intelligence for companies connected to this research.